Correlation Between Akebia Ther and PDS Biotechnology
Can any of the company-specific risk be diversified away by investing in both Akebia Ther and PDS Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Akebia Ther and PDS Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Akebia Ther and PDS Biotechnology Corp, you can compare the effects of market volatilities on Akebia Ther and PDS Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Akebia Ther with a short position of PDS Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Akebia Ther and PDS Biotechnology.
Diversification Opportunities for Akebia Ther and PDS Biotechnology
-0.6 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Akebia and PDS is -0.6. Overlapping area represents the amount of risk that can be diversified away by holding Akebia Ther and PDS Biotechnology Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on PDS Biotechnology Corp and Akebia Ther is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Akebia Ther are associated (or correlated) with PDS Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of PDS Biotechnology Corp has no effect on the direction of Akebia Ther i.e., Akebia Ther and PDS Biotechnology go up and down completely randomly.
Pair Corralation between Akebia Ther and PDS Biotechnology
Given the investment horizon of 90 days Akebia Ther is expected to generate 0.65 times more return on investment than PDS Biotechnology. However, Akebia Ther is 1.53 times less risky than PDS Biotechnology. It trades about 0.25 of its potential returns per unit of risk. PDS Biotechnology Corp is currently generating about -0.29 per unit of risk. If you would invest 170.00 in Akebia Ther on August 31, 2024 and sell it today you would earn a total of 36.00 from holding Akebia Ther or generate 21.18% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Akebia Ther vs. PDS Biotechnology Corp
Performance |
| Timeline |
| Akebia Ther |
| PDS Biotechnology Corp |
Akebia Ther and PDS Biotechnology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Akebia Ther and PDS Biotechnology
The main advantage of trading using opposite Akebia Ther and PDS Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Akebia Ther position performs unexpectedly, PDS Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in PDS Biotechnology will offset losses from the drop in PDS Biotechnology's long position.| Akebia Ther vs. Protalix Biotherapeutics | Akebia Ther vs. Cidara Therapeutics | Akebia Ther vs. X4 Pharmaceuticals | Akebia Ther vs. Seres Therapeutics |
| PDS Biotechnology vs. Mereo BioPharma Group | PDS Biotechnology vs. Terns Pharmaceuticals | PDS Biotechnology vs. Inozyme Pharma | PDS Biotechnology vs. Hookipa Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Complementary Tools
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |